Basel Medical Group (BMGL) Competitors $1.98 -0.02 (-1.00%) As of 09/12/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BMGL vs. CORBF, SERA, QIPT, BNR, BDSX, ATPC, PIII, EUDA, MGRX, and MRAIShould you be buying Basel Medical Group stock or one of its competitors? The main competitors of Basel Medical Group include Global Cord Blood (CORBF), Sera Prognostics (SERA), Quipt Home Medical (QIPT), Burning Rock Biotech (BNR), Biodesix (BDSX), Agape ATP (ATPC), P3 Health Partners (PIII), EUDA Health (EUDA), Mangoceuticals (MGRX), and Marpai (MRAI). These companies are all part of the "healthcare" industry. Basel Medical Group vs. Its Competitors Global Cord Blood Sera Prognostics Quipt Home Medical Burning Rock Biotech Biodesix Agape ATP P3 Health Partners EUDA Health Mangoceuticals Marpai Basel Medical Group (NASDAQ:BMGL) and Global Cord Blood (NYSE:CORBF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership. Does the media favor BMGL or CORBF? In the previous week, Basel Medical Group had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 1 mentions for Basel Medical Group and 0 mentions for Global Cord Blood. Basel Medical Group's average media sentiment score of 1.89 beat Global Cord Blood's score of 0.00 indicating that Basel Medical Group is being referred to more favorably in the media. Company Overall Sentiment Basel Medical Group Very Positive Global Cord Blood Neutral Is BMGL or CORBF more profitable? Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A Global Cord Blood N/A N/A N/A Which has preferable earnings and valuation, BMGL or CORBF? Global Cord Blood has higher revenue and earnings than Basel Medical Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical GroupN/AN/AN/AN/AN/AGlobal Cord Blood$196.12M0.62$79.04MN/AN/A SummaryBasel Medical Group beats Global Cord Blood on 2 of the 3 factors compared between the two stocks. Get Basel Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BMGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BMGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BMGL vs. The Competition Export to ExcelMetricBasel Medical GroupMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$36.91M$7.66B$5.87B$10.14BDividend YieldN/A2.77%5.68%4.59%P/E RatioN/A74.0174.5225.93Price / SalesN/A42.20548.33126.97Price / CashN/A24.1437.5660.44Price / BookN/A7.3512.166.29Net IncomeN/A$238.91M$3.28B$270.77M7 Day Performance-1.98%2.63%0.87%3.88%1 Month Performance-5.71%1.47%4.96%4.88%1 Year PerformanceN/A16.57%60.74%26.01% Basel Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BMGLBasel Medical GroupN/A$1.98-1.0%N/AN/A$36.91MN/A0.0036CORBFGlobal Cord BloodN/A$1.05flatN/A-42.9%$127.63M$196.12M0.001,200Gap DownSERASera Prognostics1.1854 of 5 stars$3.34-2.1%N/A-57.5%$125.83M$108K-3.93120News CoverageQIPTQuipt Home Medical1.9125 of 5 stars$2.59-0.4%$3.15+21.6%-3.6%$112.52M$238.38M-10.791,200Positive NewsBNRBurning Rock Biotech0.8566 of 5 stars$8.30-1.8%N/A+144.0%$89.25M$70.67M-4.391,390Earnings ReportBDSXBiodesix3.4138 of 5 stars$0.44-0.4%$1.75+296.5%-79.2%$64.72M$71.32M-1.52220News CoverageAnalyst UpgradeStock SplitATPCAgape ATP0.8134 of 5 stars$1.29-2.3%N/A-8.9%$64.51M$1.45M-3.1540News CoveragePositive NewsShort Interest ↓PIIIP3 Health Partners2.8403 of 5 stars$8.77+0.1%$16.25+85.3%-65.6%$63.03M$1.46B-0.19500Positive NewsEUDAEUDA Health0.5261 of 5 stars$1.46-2.7%N/A-69.6%$54.25M$4.01M0.002Short Interest ↑MGRXMangoceuticals0.6712 of 5 stars$2.21-0.5%N/A-96.2%$23.29M$516.03K-0.573News CoverageShort Interest ↑MRAIMarpaiN/A$1.34-0.7%N/A+117.7%$23.14M$34.87M-0.51150Gap Down Related Companies and Tools Related Companies CORBF Alternatives SERA Alternatives QIPT Alternatives BNR Alternatives BDSX Alternatives ATPC Alternatives PIII Alternatives EUDA Alternatives MGRX Alternatives MRAI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BMGL) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Basel Medical Group Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Basel Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BMGL Stock Alerts